After an early lead in Semaglutide generics, Torrent Pharmaceuticals is now positioning itself for what could be a more differentiated play—bringing the US-approved liver disease drug Resmetirom to India once…
Category: Companies
Fortis Healthcare Q4 PAT surges 44.2% to ₹271.2 cr; FY26 revenue up 17%
Fortis Healthcare has reported a 44.23 per cent rise in its consolidated profit after tax to ₹271.19 crore for the March 2026 quarter. The company had posted a profit after…
Minda Corp Q4 profit surges 138% to ₹124 crore on strong demand
reported its strongest-ever quarterly and annual performance in FY26, driven by rising electronics content in vehicles, premiumisation trends and growing demand across two-wheelers and commercial vehicles. Revenue from operations rose…
SPIC Q4 profit up on better cost control
Southern Petrochemical Industries Corporation Ltd reported a consolidated net profit of ₹29.5 crore for the quarter ended March 2026 (Q4FY26) as against ₹19.5 crore in the same quarter last year.…
Goldman Sachs, Societe Generale, others buy 1.3% stake in Paytm for ₹963 cr
Global financial institutions, including Goldman Sachs, Societe Generale, and Citigroup Global Markets, have collectively acquired a 1.34 per cent stake in , the parent company of Paytm, from SAIF Partners…
Consumer Affairs Ministry to investigate cancellation policies of online ticket platforms
Minister of Consumer Affairs, Food and Public Distribution, Pralhad Joshi, on Saturday directed the Consumer Affairs Ministry and the Central Consumer Protection Authority to launch an investigation into cancellation charges…
Gokaldas Exports Q4 consolidated net down by 31.97% at ₹35.96 crore
Apparel manufacturer Gokaldas Exports has reported a 31.97 per cent year-on-year decline in consolidated net profit to ₹35.96 crore during the quarter ended March 31, due to disruptions following US…
Venus Remedies gets Saudi FDA approval for speciality oncology therapy
Pharma major Venus Remedies Limited on Saturday said it has received marketing authorisation from the Saudi Food and Drug Authority (SFDA) for speciality oncology therapy — Plerixafor. Plerixafor is a…
Seven ways AI is making 2025 tech layoffs different from Silicon Valley’s earlier job cuts
The latest wave of tech looks very different from the massive workforce cuts that hit Silicon Valley during 2022 and 2023. Earlier layoffs were largely driven by pandemic overhiring, slowing…
Green SM’s cyan EV fleet, ₹35,000 driver guarantee signal Vingroup’s big India bet
If you have been driving through Delhi-Gurgaon and NCR recently, chances are you have already spotted the bright turquoise-cyan electric vehicles carrying the Green SM logo and wondered whether this…